Core needle biopsy from the tumor in the right breast revealed a scirrhous carcinoma, a subtype of invasive ductal carcinoma, that was positive for estrogen receptors (ERs) but negative for progesterone receptors (PgRs) and HER2/Neu. This evidence concerns the gene ERBB2 and scirrhous adenocarcinoma.